Japan
· Delayed Price · Currency is JPY SanBio Company Statistics
Total Valuation
SanBio Company has a market cap or net worth of JPY 66.37 billion. The enterprise value is 63.82 billion.
| Market Cap | 66.37B |
| Enterprise Value | 63.82B |
Important Dates
The next estimated earnings date is Monday, December 16, 2024.
| Earnings Date | Dec 16, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SanBio Company has 68.63 million shares outstanding. The number of shares has increased by 6.90% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 68.63M |
| Shares Change (YoY) | +6.90% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 28.16% |
| Owned by Institutions (%) | -4.37% |
| Float | 48.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 42.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -29.46 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -16.63 |
Financial Position
The company has a current ratio of 5.30, with a Debt / Equity ratio of 0.34.
| Current Ratio | 5.30 |
| Quick Ratio | 4.75 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -378.25 |
Financial Efficiency
Return on equity (ROE) is -114.03% and return on invested capital (ROIC) is -73.75%.
| Return on Equity (ROE) | -114.03% |
| Return on Assets (ROA) | -44.85% |
| Return on Capital (ROIC) | -73.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -74.69M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +111.62% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +111.62% |
| 50-Day Moving Average | 1,067.22 |
| 200-Day Moving Average | 816.13 |
| Relative Strength Index (RSI) | 42.51 |
| Average Volume (20 Days) | 876,740 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.03B |
| Pretax Income | -1.87B |
| Net Income | -2.17B |
| EBITDA | -3.02B |
| EBIT | -3.03B |
| Earnings Per Share (EPS) | -32.23 |
Balance Sheet
The company has 3.08 billion in cash and 531.00 million in debt, giving a net cash position of 2.55 billion or 37.16 per share.
| Cash & Cash Equivalents | 3.08B |
| Total Debt | 531.00M |
| Net Cash | 2.55B |
| Net Cash Per Share | 37.16 |
| Equity (Book Value) | 1.57B |
| Book Value Per Share | 22.89 |
| Working Capital | 2.79B |
Cash Flow
In the last 12 months, operating cash flow was -3.83 billion and capital expenditures -6.00 million, giving a free cash flow of -3.84 billion.
| Operating Cash Flow | -3.83B |
| Capital Expenditures | -6.00M |
| Free Cash Flow | -3.84B |
| FCF Per Share | -55.91 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SanBio Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.90% |
| Shareholder Yield | -6.90% |
| Earnings Yield | -3.33% |
| FCF Yield | -5.78% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |